Ligand Pharmaceuticals Incorporated monthly returns
Ligand Pharmaceuticals Incorporated has averaged 1.71% per month, positive in 53% of months. Month-by-month returns for Ligand Pharmaceuticals Incorporated (LGND) below, through October 16, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Ligand Pharmaceuticals Incorporated monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -5.4% | |
| Sep 2026 | +10.0% | |
| Aug 2026 | -1.2% | |
| Jul 2026 | -9.0% | |
| Jun 2026 | +36.3% | |
| May 2026 | +1.1% | |
| Apr 2026 | +14.9% | |
| Mar 2026 | +0.7% | |
| Feb 2026 | +3.2% | |
| Jan 2026 | +1.6% | |
| Dec 2025 | -6.9% | |
| Nov 2025 | +6.2% | |
| Oct 2025 | +8.0% | |
| Sep 2025 | +9.5% | |
| Aug 2025 | +22.9% | |
| Jul 2025 | +15.7% | |
| Jun 2025 | +11.2% | |
| May 2025 | -7.0% | |
| Apr 2025 | +4.5% | |
| Mar 2025 | -14.0% | |
| Feb 2025 | +4.9% | |
| Jan 2025 | +8.8% | |
| Dec 2024 | -11.8% | |
| Nov 2024 | +14.9% | |
| Oct 2024 | +5.6% | |
| Sep 2024 | -5.4% | |
| Aug 2024 | -2.9% | |
| Jul 2024 | +29.3% | |
| Jun 2024 | -0.9% | |
| May 2024 | +21.7% | |
| Apr 2024 | -4.4% | |
| Mar 2024 | -7.9% | |
| Feb 2024 | +8.5% | |
| Jan 2024 | +2.4% | |
| Dec 2023 | +22.5% | |
| Nov 2023 | +11.5% | |
| Oct 2023 | -12.7% | |
| Sep 2023 | -8.9% | |
| Aug 2023 | -1.7% | |
| Jul 2023 | -7.2% | |
| Jun 2023 | +2.9% | |
| May 2023 | -8.2% | |
| Apr 2023 | +3.8% | |
| Mar 2023 | +2.0% | |
| Feb 2023 | +3.5% | |
| Jan 2023 | +4.3% | |
| Dec 2022 | -8.4% | |
| Nov 2022 | +33.3% | |
| Oct 2022 | +1.8% | |
| Sep 2022 | -6.8% | |
| Aug 2022 | +0.4% | |
| Jul 2022 | +3.1% | |
| Jun 2022 | +0.3% | |
| May 2022 | -4.3% | |
| Apr 2022 | -17.5% | |
| Mar 2022 | +11.1% | |
| Feb 2022 | -18.8% | |
| Jan 2022 | -19.3% | |
| Dec 2021 | -4.6% | |
| Nov 2021 | +10.9% | |
| Oct 2021 | +4.8% | |
| Sep 2021 | +5.3% | |
| Aug 2021 | +16.6% | |
| Jul 2021 | -13.5% | |
| Jun 2021 | +11.5% | |
| May 2021 | -19.3% | |
| Apr 2021 | -4.3% | |
| Mar 2021 | +2.9% | |
| Feb 2021 | -20.0% | |
| Jan 2021 | +86.4% | |
| Dec 2020 | +17.9% | |
| Nov 2020 | +2.3% | |
| Oct 2020 | -13.5% | |
| Sep 2020 | -6.5% | |
| Aug 2020 | -13.0% | |
| Jul 2020 | +4.8% | |
| Jun 2020 | +10.1% | |
| May 2020 | +3.0% | |
| Apr 2020 | +35.5% | |
| Mar 2020 | -22.3% | |
| Feb 2020 | +6.6% | |
| Jan 2020 | -15.8% | |
| Dec 2019 | -7.7% | |
| Nov 2019 | +3.9% | |
| Oct 2019 | +9.3% | |
| Sep 2019 | +9.5% | |
| Aug 2019 | -0.7% | |
| Jul 2019 | -19.8% | |
| Jun 2019 | +6.3% | |
| May 2019 | -14.7% | |
| Apr 2019 | +0.1% | |
| Mar 2019 | +1.3% | |
| Feb 2019 | +5.1% | |
| Jan 2019 | -13.0% | |
| Dec 2018 | -14.0% | |
| Nov 2018 | -4.3% | |
| Oct 2018 | -40.0% | |
| Sep 2018 | +5.7% | |
| Aug 2018 | +18.9% | |
| Jul 2018 | +5.4% | |
| Jun 2018 | +7.8% | |
| May 2018 | +24.1% | |
| Apr 2018 | -6.2% | |
| Mar 2018 | +8.7% | |
| Feb 2018 | -3.6% | |
| Jan 2018 | +15.1% | |
| Dec 2017 | +3.9% | |
| Nov 2017 | -9.3% | |
| Oct 2017 | +6.8% | |
| Sep 2017 | +5.6% | |
| Aug 2017 | +6.6% | |
| Jul 2017 | -0.4% | |
| Jun 2017 | +12.1% | |
| May 2017 | -2.6% | |
| Apr 2017 | +5.0% | |
| Mar 2017 | +1.2% | |
| Feb 2017 | -1.3% | |
| Jan 2017 | +4.3% | |
| Dec 2016 | -2.7% | |
| Nov 2016 | +9.1% |
Monthly total return (since Nov 2021)#
Ligand Pharmaceuticals Incorporated returns by calendar month#
Every month of every year since 1993, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -5.39% — 22nd of 34 Octobers since 1993 at the last close; the average October returned +0.2%.
| Month | −90%0+90% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +1.1% | -0.2% | 50% | +86.4% 2021 | -22.6% 2009 | |
| Feb | +1.4% | -0.9% | 47% | +55.4% 2000 | -23.8% 1999 | |
| Mar | +2.7% | +1.2% | 56% | +40.0% 2015 | -41.5% 2005 | |
| Apr | +0.8% | +0.2% | 53% | +37.3% 2003 | -32.4% 2007 | |
| May | +1.6% | -0.7% | 47% | +42.9% 2003 | -19.3% 2021 | |
| Jun | +5.1% | +6.4% | 62% | +40.4% 1995 | -25.9% 2008 | |
| Jul | -1.1% | -0.7% | 47% | +29.3% 2024 | -38.2% 2002 | |
| Aug | -1.8% | +0.5% | 53% | +30.0% 2000 | -48.3% 1998 | |
| Sep | +2.1% | -0.9% | 44% | +58.7% 1998 | -14.8% 2007 | |
| Oct | +0.2% | +2.5% | 58% | +46.7% 2001 | -40.0% 2018 | |
| Nov | +4.2% | +2.3% | 52% | +40.5% 1999 | -21.1% 2002 | |
| Dec | +4.4% | +2.2% | 67% | +33.0% 2008 | -14.0% 2018 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from LGND's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Ligand Pharmaceuticals Incorporated's average monthly return?
- Ligand Pharmaceuticals Incorporated (LGND) has averaged about 1.71% per month, positive in roughly 53% of months. The best month was Jan 2021 (+86.4%) and the worst was Aug 1998 (-48.3%).
